Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients with Uterine Cervical Non-Squamous Cell Carcinoma after Radical Hysterectomy

Seiya Sato, Muneaki Shimada, Tsuyoshi Ohta, Takanobu Kojimahara, Hideki Tokunaga, Tadao Takano, Satoshi Yamaguchi, Hiroshi Tanabe, Shin Nishio, Junzo Kigawa

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Objective We conducted this study to evaluate the efficacy and safety of adjuvant chemotherapy using taxane plus carboplatin (CBDCA) for high-risk stage IB-IIB patients with uterine cervical non-squamous cell carcinoma after radical hysterectomy. Methods Thirty-seven patients were eligible. Pelvic lymph node involvement and/or parametrial invasion were defined as high-risk factors. The patients were treated with 6 cycles of paclitaxel (PTX, 175 mg/m2) or docetaxel (DTX, 60 mg/m2) followed by CBDCA (area under the curve, 6) every 3 weeks. The primary end point was 2-year progression-free survival (PFS) rate, and the secondary end point was the assessment of adverse events. Results Twenty-two patients received PTX/CBDCA (TC) chemotherapy, and the remaining 15 patients underwent DTX/CBDCA (DC) chemotherapy. The 2-year PFS rate was 62.1% (95% confidence interval, 44.6%-75.5%). Patients receiving DC chemotherapy showed a better 2-year PFS rate compared to those with TC chemotherapy, but the difference was not statistically significant (80.0% vs 50.0%, P = 0.1400). The most common grade 3/4 adverse events were hematologic toxicities, which were generally well tolerable. Nonhematologic toxicity was generally mild. Conclusions Taxane and CBDCA combination chemotherapy, especially DC chemotherapy, may be one of the useful adjuvant treatments for high-risk stage IB-IIB patients with uterine cervical non-squamous cell carcinoma after radical hysterectomy.

Original languageEnglish
Pages (from-to)561-567
Number of pages7
JournalInternational Journal of Gynecological Cancer
Volume26
Issue number3
DOIs
Publication statusPublished - 2016 Mar 1
Externally publishedYes

Keywords

  • Adjuvant chemotherapy
  • Cervical cancer
  • Non-squamous cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients with Uterine Cervical Non-Squamous Cell Carcinoma after Radical Hysterectomy'. Together they form a unique fingerprint.

Cite this